My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 328

    1.

    Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia.

    Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvey WT, Klein RL; DCC/EDIC Research Group.

    Diabetes Care. 2003 Mar;26(3):810-8.PMID: 12610042 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.

    Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvey WT, Klein RL; DCCT/EDIC Research Group.

    Kidney Int. 2003 Sep;64(3):817-28.PMID: 12911531 [PubMed - indexed for MEDLINE]Related articles

    3.

    Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.

    Lyons TJ, Jenkins AJ, Zheng D, Lackland DT, McGee D, Garvey WT, Klein RL.

    Invest Ophthalmol Vis Sci. 2004 Mar;45(3):910-8.PMID: 14985310 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.

    Lyons TJ, Jenkins AJ, Zheng D, Klein RL, Otvos JD, Yu Y, Lackland DT, McGee D, McHenry MB, Lopes-Virella M, Garvey WT; DCCT/EDIC Research Group.

    Diabet Med. 2006 Sep;23(9):955-66.PMID: 16922701 [PubMed - indexed for MEDLINE]Related articles

    5.

    Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses.

    Klein RL, McHenry MB, Lok KH, Hunter SJ, Le NA, Jenkins AJ, Zheng D, Semler AJ, Brown WV, Lyons TJ, Garvey WT; DCCT/EDIC Research Group.

    Metabolism. 2004 Oct;53(10):1296-304.PMID: 15375785 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.

    Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao Y.

    Diabetes. 2003 Feb;52(2):453-62.PMID: 12540621 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.

    Soedamah-Muthu SS, Chang YF, Otvos J, Evans RW, Orchard TJ; Pittsburgh Epidemiology of Diabetes Complications Study.

    Diabetologia. 2003 May;46(5):674-82. Epub 2003 May 13.PMID: 12743701 [PubMed - indexed for MEDLINE]Related articles

    8.

    Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.

    Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH.

    Diabetes. 2002 Jun;51(6):1949-56.PMID: 12031985 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.

    Idzior-Walus B, Mattock MB, Solnica B, Stevens L, Fuller JH; EURODIAB IDDM Complications Study Group.

    Diabet Med. 2001 Oct;18(10):786-96.PMID: 11678968 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort.

    Jenkins AJ, Rothen M, Klein RL, Moller K, Eldridge L, Zheng D, Durazo-Arvizu R, McGee D, Lackland D, Thorpe SR, Garvey WT, Lyons TJ; DCCT/EDIC Research Group.

    J Diabetes Complications. 2008 May-Jun;22(3):153-63. Epub 2008 Apr 16.PMID: 18413218 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of obesity and body fat distribution on lipids and lipoproteins in nondiabetic American Indians: The Strong Heart Study.

    Hu D, Hannah J, Gray RS, Jablonski KA, Henderson JA, Robbins DC, Lee ET, Welty TK, Howard BV.

    Obes Res. 2000 Sep;8(6):411-21.PMID: 11011907 [PubMed - indexed for MEDLINE]Related articles

    12.

    Serum lipids and glucose control: the SEARCH for Diabetes in Youth study.

    Petitti DB, Imperatore G, Palla SL, Daniels SR, Dolan LM, Kershnar AK, Marcovina S, Pettitt DJ, Pihoker C; SEARCH for Diabetes in Youth Study Group.

    Arch Pediatr Adolesc Med. 2007 Feb;161(2):159-65.PMID: 17283301 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women.

    Magkos F, Mohammed BS, Mittendorfer B.

    Int J Obes (Lond). 2008 Nov;32(11):1655-64. Epub 2008 Sep 9.PMID: 18779822 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.

    Romero P, Salvat M, Fernández J, Baget M, Martinez I.

    J Diabetes Complications. 2007 Mar-Apr;21(2):93-100.PMID: 17331857 [PubMed - indexed for MEDLINE]Related articles

    15.

    Peroxisome proliferator-activated receptor-gamma agonist increases both low-density lipoprotein cholesterol particle size and small high-density lipoprotein cholesterol in patients with type 2 diabetes independent of diabetic control.

    Bavirti S, Ghanaat F, Tayek JA.

    Endocr Pract. 2003 Nov-Dec;9(6):487-93.PMID: 14715475 [PubMed - indexed for MEDLINE]Related articles

    16.

    Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes.

    Chaturvedi N, Fuller JH, Taskinen MR; EURODIAB PCS Group.

    Diabetes Care. 2001 Dec;24(12):2071-7.PMID: 11723085 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Effect of LDL+VLDL oxidizability and hyperglycemia on blood cholesterol, phospholipid and triglyceride levels in type-I diabetic patients.

    Jain SK, McVie R, Meachum ZD, Smith T.

    Atherosclerosis. 2000 Mar;149(1):69-73.PMID: 10704616 [PubMed - indexed for MEDLINE]Related articles

    18.

    Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes.

    Laakso M, Pyörälä K.

    Metabolism. 1990 Feb;39(2):117-22.PMID: 2299984 [PubMed - indexed for MEDLINE]Related articles

    19.

    Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.

    [No authors listed]

    Diabetes Care. 1999 Jan;22(1):99-111.PMID: 10333910 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The effects of gender and age on associations between blood lipid levels and obesity in Danish men and women aged 35-65 years.

    Heitmann BL.

    J Clin Epidemiol. 1992 Jul;45(7):693-702.PMID: 1619448 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity